Overview
General focus: My research interests are in primary and secondary prevention of cardiovascular disease. Specifically, I am looking at compliance issues within the cardiology division and in the University as a whole with regard to evidence based treatment and secondary prevention of cardiovascular disease. I am using both retrospective and prospective collection of discharge data to try and analyze these trends. In the future, we hope to begin clinical trials with regard to various issues which are outstanding in primary and secondary prevention. Some of the issues include treatment of hypercholesterolemia in elderly patients, differences between the various statins with regard to affects on lipid profiles, and early treatment of hypercholesterolemia after MI.
As part of my work, I have served as a consultant with various drug companies with regard to focusing on active issues and treatment of hypercholesterolemia.
Key words: Primary prevention, secondary prevention, hyperlipidemia, homocysteine, and hypertension.
As part of my work, I have served as a consultant with various drug companies with regard to focusing on active issues and treatment of hypercholesterolemia.
Key words: Primary prevention, secondary prevention, hyperlipidemia, homocysteine, and hypertension.
Current Appointments & Affiliations
Associate Professor of Medicine
·
2007 - Present
Medicine, Cardiology,
Medicine
Recent Publications
Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials.
Journal Article Lancet · February 14, 2026 BACKGROUND: Statin product labels (eg, Summaries of Product Characteristics [SmPCs]) list certain adverse outcomes as potential treatment-related effects based mainly on non-randomised and non-blinded studies, which might be subject to bias. We aimed to as ... Full text Link to item CiteEffects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Journal Article Lancet Diabetes Endocrinol · May 2024 BACKGROUND: Previous meta-analyses of summary data from randomised controlled trials have shown that statin therapy increases the risk of diabetes, but less is known about the size or timing of this effect, or who is at greatest risk. We aimed to address t ... Full text Link to item CiteWhy Novel Therapies in Preventive Cardiology May Face a Marathon, Not a Sprint.
Journal Article Circulation · September 12, 2023 Full text Link to item CiteRecent Grants
Radiation-Induced Cardiopulmonary Injury in Humans
ResearchInvestigator · Awarded by National Institutes of Health · 1996 - 2008Anxiety, Depression, and Non-Cardiac Chest Pain
ResearchCo Investigator · Awarded by National Institutes of Health · 2001 - 2007View All Grants
Education, Training & Certifications
University of California San Francisco, School of Medicine ·
1987
M.D.